ESC Premium Access

Transvenous carotid body ablation for resistant hypertension: main results of a multicentre safety and proof-of-principle cohort study.

Topic: Device Treatment and Intervention

Congress Presentation

About the speaker

Professor Markus Schlaich

Royal Perth Hospital - University of Western Australia, Perth (Australia)
0 follower

4 more presentations in this session

Device-based therapy in hypertension - State of the Art

Speaker: Professor F. Mahfoud (Homburg, DE)


Evaluation of later morphologic alterations in renal artery wall and nerves in response to catheter-based renal denervation in sheep: comparison of the single-point and multiple-point RDN catheters

Speaker: Professor M. Taborsky (Olomouc, CZ)


Refractory and resistant hypertension in diabetic patients: different metabolic profile, different response to renal denervation

Speaker: Doctor A. Falkovskaya (Tomsk, RU)


Cancelled presentation - The sympathetic nervous system in hypertension: a rational treatment target?


Access the full session

Device-based therapy in hypertension

Speakers: Professor M. Schlaich, Professor F. Mahfoud, Professor M. Taborsky, Doctor A. Falkovskaya

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb